Ery-Ped (erythromycin ethylsuccinate) NDC 24338-130

NDC codes

FDA NDC Directory

Product NDC (as listed)24338-130Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24338-0130Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24338-130-13	24338013013	100 mL in 1 BOTTLE (24338-130-13)Marketed from Jun 14, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ery-Ped
Generic name (nonproprietary): erythromycin ethylsuccinate
Active ingredients: Erythromycin ethylsuccinate — 400 mg/5mL
Dosage form: Suspension
Route: Oral
Labeler: Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 050207
Marketing start: Jun 14, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 24338-130_0ca6c02b-5b9f-39c3-e063-6294a90a4c18SPL ID 0ca6c02b-5b9f-39c3-e063-6294a90a4c18SPL set ID 04775721-ab87-4b66-808c-d67a21032385RxCUI 686400, 686402, 686418, 686420UNII 1014KSJ86F
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424338013013 followed by a unit qualifier and the quantity

Package 24338-0130-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 16, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ery-Ped and other antibacterial drugs, Ery-Ped should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Ery-Ped is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below: Upper respirato…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 050207

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 050207
Product	Strength	Form · route	Labeler	Product NDC
Erythromycin Ethylsuccinate	Erythromycin ethylsuccinate 200 mg/5mL	Granule, For suspensionOral	Wilshire Pharmaceuticals Inc.	52536-134
Erythromycin Ethylsuccinate	Erythromycin ethylsuccinate 400 mg/5mL	SuspensionOral	Wilshire Pharmaceuticals	52536-130
Erythromycin Ethylsuccinate	Erythromycin ethylsuccinate 200 mg/5mL	SuspensionOral	Wilshire Pharmaceuticals	52536-132
Erythromycin Ethylsuccinate	Erythromycin ethylsuccinate 200 mg/5mL	Granule, For suspensionOral	Wilshire Pharmaceuticals Inc.	52536-136
Ery-Pederythromycin ethylsuccinate	Erythromycin ethylsuccinate 200 mg/5mL	SuspensionOral	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	24338-132
E.E.Serythromycin ethylsuccinate	Erythromycin ethylsuccinate 200 mg/5mL	Granule, For suspensionOral	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	24338-134
E.E.Serythromycin ethylsuccinate	Erythromycin ethylsuccinate 200 mg/5mL	Granule, For suspensionOral	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	24338-136